Biofrontera (BFRI) EBITDA Margin (QoQ) (2020 - 2025)
Biofrontera (BFRI) EBITDA Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.38 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.66 Bn | 40.00 Bn | 2.15 Bn |
| 3 | Zoetis | 32.33 Bn | 30.66 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.04 Bn | 19.37 Bn | 683.80 Mn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Biofrontera | 19.32 Mn | 14.61 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,650.00 |
| Sep 30, 2025 | -3,359.00 |
| Jun 30, 2025 | -330.00 |
| Mar 31, 2025 | -3,931.00 |
| Dec 31, 2024 | 4,141.00 |
| Sep 30, 2024 | 965.00 |
| Jun 30, 2024 | 441.00 |
| Mar 31, 2024 | -3,262.00 |
| Dec 31, 2023 | 1,546.00 |
| Sep 30, 2023 | 9,682.00 |
| Jun 30, 2023 | -8,586.00 |
| Mar 31, 2023 | -787.00 |
| Dec 31, 2022 | 2,918.00 |
| Sep 30, 2022 | 5,518.00 |
| Jun 30, 2022 | -10,748.00 |
| Mar 31, 2022 | -4,467.00 |
| Dec 31, 2021 | 38,438.00 |
| Sep 30, 2021 | -30,862.00 |
| Jun 30, 2021 | 1,081.00 |
| Mar 31, 2021 | -7,158.00 |